Enanta Pharmaceuticals (ENTA) Gross Profit: 2012-2025
Historic Gross Profit for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to $15.1 million.
- Enanta Pharmaceuticals' Gross Profit rose 3.55% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.3 million, marking a year-over-year decrease of 3.42%. This contributed to the annual value of $65.3 million for FY2025, which is 3.42% down from last year.
- Per Enanta Pharmaceuticals' latest filing, its Gross Profit stood at $15.1 million for Q3 2025, which was down 17.41% from $18.3 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Gross Profit registered a high of $27.6 million during Q4 2021, and its lowest value of $14.6 million during Q3 2024.
- In the last 3 years, Enanta Pharmaceuticals' Gross Profit had a median value of $17.8 million in 2023 and averaged $17.1 million.
- Within the past 5 years, the most significant YoY rise in Enanta Pharmaceuticals' Gross Profit was 15.93% (2021), while the steepest drop was 27.11% (2021).
- Over the past 5 years, Enanta Pharmaceuticals' Gross Profit (Quarterly) stood at $27.6 million in 2021, then dropped by 14.70% to $23.6 million in 2022, then declined by 23.67% to $18.0 million in 2023, then declined by 5.80% to $17.0 million in 2024, then rose by 3.55% to $15.1 million in 2025.
- Its last three reported values are $15.1 million in Q3 2025, $18.3 million for Q2 2025, and $14.9 million during Q1 2025.